参考文献/References:
1 Tyldesley S,Boyd C,Schiclze K,et al.Estimating the need for radiotherapy for lung cancer:an evidence-based epidemiologic approach.Int J Radiat Oncol Biol Phys,2001,49 (4):973-985.
2 Rivera MP.Multimodality therapy in the treatment of lung cancer.Semin Respir Crit Care Med,2004,25(Suppl 1):3-10.
3 Santos R,Colonias A,Parda D,et al.Comparison between sublobar resection and 125-Iodine brachytherapy after sublobar resection in high-risk patients with stage I non-small-cell lung cancer.Surgery,2003,134(4):691-697.
4 Timmerman R,Papiez L,McGarry R,et al.Extracranial stereotactic radioablation:Results of a phase I study in medically inoperable stage I non-small cell iung cancer.Chest,2003,124(5):1946-1955.
5 Williamson JF,Coursey BM,Dewerd LA,et al.On the use of apparent activity (Aapp) for treatment planning of 125I and 100pd interstitial brachytherapy sources:recommendations of the American Association of Physicists in Medicine radiation therapy subcommittee on low-energy brachytherapy source dosimetry.Med Phys,1999,26(12):2529-2530.
6 Voynov G,Heron DE,Lin CJ,et al.Intraoperative 125I vicryl mesh brachytherapy after sublobar resection for high-risk stage I non-small cell lung cancer.Brachytherapy,2005,4(4):278-285.
7 Uematsu M,Shioda A,Suda A,et al.Computed tomography-guided frameless stereotactic radiotherapy for stage 1 non small cell lung cancer:A 5-year experience.Int J Radiat Oncol Biol Phys,2001,51,(3):666-670.
8 Martinez-Monge R,Garrán C,Vivas I,et al.Percutaneous CT-guided 103Pd implantation for the medically inoperable patient with T1N0M0 non-small cell lung cancer:A case report.Brachytherapy,2004,3(3):179-181.
9 Fernando HC,Santos RS,Benfield JR.Lobar and sublobar resection with and without brachytherapy for small stage IA non-small cell lung cancer.J Thorac Cardiovasc Surg,2005,129(2):261-267.
10 Birdas TJ,Koehler RP,Colonias A.Sublobar resection with brachytherapy versus lobectomy for stage lb non small cell lung cancer.Ann Thorac Surg,2006,81(2):434-439.
11 Chen A,Galloway M,Landreneau R,et al.intraoperative 125Ibrachytherapy for high-risk stage I non-small cell lung carcinoma,Int J Radiat Oncol Biol Phys,1999,44(5):1057-1063.
12 Nori D,Li X,Pugkhem T.Intraoperative brachytherapy using Gelfoam radioactive plaque implants for resected stage III non-small cell lung cancer with positive margin:A pilot study.J Surg Oncol,1995,60(4):257-261.
13 Birdas TJ,Koehler RP,Colonia SA,et al.Sublobar resection with brachytherapy versus lobectomy for stage ib nonsmall cell lung cancer.Ann Thorac Surg,2006,81(2):434-438.
14 Lee W,Daly BD,Dipetrillo TA,et al.Limited resection for non-small cell lung cancer observed local control with implantation of I-125 brachytherapy seeds.Ann Thorac Surg,2003,75(1):237-242.
15 Nag S,Kelly JF,Non D.Brachytherapy for carcinoma of the lung.Oncology (Huntington),2001,15(3):371-381.
16 d’Amato TA,Galloway M,Szydlowaki G,et al.Intraoperative brachytherapy following thoracoscopic wedge resection of stage I lung cancer.Chest,1998,114(4):1112-1115.
17 Pisch J,Belsley SJ,Ashton R,et al.Placement of 125I implants with the da vinci robotic system after video-assisted thoracoscopic wedge resection:a feasibility study.Int J Radiat Oncol Biol Phys,2004,60(3):928-932.
相似文献/References:
[1]李景涛,邓垒,张文珏,等.广泛期小细胞肺癌胸部IMRT后发生放射性肺炎的危险因素分析[J].国际放射医学核医学杂志,2016,40(2):100.[doi:10.3760/cma.j.issn.1673-4114.2016.02.003]
Li Jingtao,Deng Lei,Zhang Wenjue,et al.Risk factor analysis for predicting radiation pneumonitis in extensive stage small cell lung cancer patients receiving IMRT thoracic radiotherapy[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(3):100.[doi:10.3760/cma.j.issn.1673-4114.2016.02.003]
[2]田琦,张丽花,蒋宁一.甲状腺癌131I治疗后合并骨髓增生异常综合征一例[J].国际放射医学核医学杂志,2016,40(3):235.[doi:10.3760/cma.j.issn.1673-4114.2016.03.014]
[3]霍小东,王慧星,阎卫亮,等.血管内皮抑制素对125I近距离照射裸鼠肺癌移植瘤的增敏效应研究[J].国际放射医学核医学杂志,2016,40(5):357.[doi:10.3760/cma.j.issn.1673-4114.2016.05.006]
Huo Xiaodong,Wang Huixing,Yan Weiliang,et al.Sensitization effect of endostatin for 125I brachytherapy on transplanted tumor in nude mice[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(3):357.[doi:10.3760/cma.j.issn.1673-4114.2016.05.006]
[4]徐蓉生,梅艳,赵力威,等.B超引导下术中125I粒子植入治疗晚期胰腺癌的疗效评价[J].国际放射医学核医学杂志,2016,40(6):424.[doi:10.3760/cma.j.issn.1673-4114.2016.06.005]
Xu Rongsheng,Mei Yan,Zhao Liwei,et al.Evaluation of 125I particle implantation in the treatment of patients with advanced pancreatic neoplasms using B ultrasound-guided surgery[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(3):424.[doi:10.3760/cma.j.issn.1673-4114.2016.06.005]
[5]张毓艺,姚稚明.18F-FDG PET/CT对非小细胞肺癌淋巴结分期诊断价值的研究进展[J].国际放射医学核医学杂志,2016,40(6):447.[doi:10.3760/cma.j.issn.1673-4114.2016.06.009]
Zhang Yuyi,Yao Zhiming.The progress of 18F-FDG PET/CT in the diagnosis of N-staging of non-small cell lung cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(3):447.[doi:10.3760/cma.j.issn.1673-4114.2016.06.009]
[6]张丽花,蒋宁一.131I治疗Graves甲亢合并肝功能损害或血细胞减少的优势与风险[J].国际放射医学核医学杂志,2015,39(6):483.[doi:10.3760/cma.j.issn.1673-4114.2015.06.010]
Zhang Lihua,Jiang Ningyi.The advantage and risk of 131I treatment in hyperthyroidism combined with liver injury or blood cell reduction[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(3):483.[doi:10.3760/cma.j.issn.1673-4114.2015.06.010]
[7]杨宝军.131I治疗甲亢合并特发性血小板减少性紫癜一例[J].国际放射医学核医学杂志,2015,39(6):511.[doi:10.3760/cma.j.issn.1673-4114.2015.06.017]
[8]赵腾,梁军,林岩松.131I治疗前刺激性Tg在分化型甲状腺癌风险评估及治疗决策中的意义[J].国际放射医学核医学杂志,2015,39(1):61.[doi:10.3760/cma.j.issn.1673-4114.2015.01.013]
Zhao Teng,Liang Jun,Lin Yansong.The role of preablative stimulated thyroglobulin in guiding risk estimation and therapeutic decisions of differentiated thyroid carcinoma[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(3):61.[doi:10.3760/cma.j.issn.1673-4114.2015.01.013]
[9]万绪明,许祖闪,侯红军.磁共振表观弥散系数变化率对肝细胞肝癌患者单次TACE术后疗效评价的应用价值[J].国际放射医学核医学杂志,2015,39(2):129.[doi:10.3760/cma.j.issn.1673-4114.2015.02.006]
Wan Xuming,Xu Zushan,Hou Hongjun.Applieation value of the change ratio of apparent diffusion coefficient in the therapeutic evaluation of hepatocellular carcinoma treated by single transcatheter arterial chemoembolization[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(3):129.[doi:10.3760/cma.j.issn.1673-4114.2015.02.006]
[10]王振光,王洋洋.PET/CT显像在肝细胞肝癌诊断中的研究进展[J].国际放射医学核医学杂志,2015,39(2):175.[doi:10.3760/cma.j.issn.1673-4114.2015.02.016]
Wang Zhenguang,Wang Yangyang.The development of PET/CT imaging in the diagnosis of hepatocellular carcinoma[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(3):175.[doi:10.3760/cma.j.issn.1673-4114.2015.02.016]
[11]梁吉祥,柴树德,郑广钧,等.CT引导下植入125I粒子治疗非小细胞肺癌切除术后局部复发的疗效[J].国际放射医学核医学杂志,2011,35(3):181.[doi:10.3760/cma.j.issn.1673-4114.2011.03.012]
LIANG Ji-xiang,CHAI Shu-de,ZHENG Guang-jun,et al.CT-guided percutaneous interstitial implantation of 125I for recurrent patients of postoperative non-small cell lung carcinoma[J].International Journal of Radiation Medicine and Nuclear Medicine,2011,35(3):181.[doi:10.3760/cma.j.issn.1673-4114.2011.03.012]
[12]任凌,戴皓洁.125Ⅰ粒子在头颈部腺样囊性癌综合治疗中的作用[J].国际放射医学核医学杂志,2011,35(1):13.[doi:10.3760/cma.j.issn.1673-4114.2011.01.004]
REN Ling,DAI Hao-jie.The effect of 125I seed in comprehensive therapy of the head and neck adenoid cystic carcinoma[J].International Journal of Radiation Medicine and Nuclear Medicine,2011,35(3):13.[doi:10.3760/cma.j.issn.1673-4114.2011.01.004]
[13]陆光兵,刘丽.125I粒子联合EP方案治疗局部晚期非小细胞肺癌的临床分析[J].国际放射医学核医学杂志,2010,34(2):105.[doi:10.3760/cma.j.issn.1673-4114.2010.02.012]
[14]付丽,张遵城,于兆晨,等.CT引导125I粒子治疗非小细胞肺癌的辐射防护护理干预[J].国际放射医学核医学杂志,2009,33(5):312.[doi:10.3760/cnla.j.issn.1673-4114.2009.05.018]
FU Li,ZHANG Zun-cheng,YU Zhao-chen,et al.Radiation protective nursing intervene of 125I seed implantation in non-small cell lung carcinoma guided by CT[J].International Journal of Radiation Medicine and Nuclear Medicine,2009,33(3):312.[doi:10.3760/cnla.j.issn.1673-4114.2009.05.018]
[15]李小东,郭永涛,赵洪刚,等.CT引导125I粒子植入治疗晚期非小细胞肺癌的应用[J].国际放射医学核医学杂志,2007,31(6):377.
LI Xiao-dong,GUO Yong-tao,ZHAO Hong-gang,et al.The image guided 125I seeds implantation treatment terminal non small cell lung carcinoma research of application[J].International Journal of Radiation Medicine and Nuclear Medicine,2007,31(3):377.